Edap Tms (NASDAQ:EDAP) vs. Paradigm Medical Industries (OTCMKTS:PDMI) Head-To-Head Analysis

Paradigm Medical Industries (OTCMKTS:PDMI) and Edap Tms (NASDAQ:EDAP) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Profitability

This table compares Paradigm Medical Industries and Edap Tms’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Paradigm Medical Industries	N/A	N/A	N/A
Edap Tms	-30.95%	-61.60%	-26.70%

Institutional & Insider Ownership

62.7% of Edap Tms shares are held by institutional investors. 11.1% of Paradigm Medical Industries shares are held by insiders. Comparatively, 0.2% of Edap Tms shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Paradigm Medical Industries and Edap Tms, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paradigm Medical Industries	0	0	0	0	0.00
Edap Tms	1	2	1	0	2.00

Edap Tms has a consensus price target of $8.50, suggesting a potential upside of 100.00%. Given Edap Tms’ stronger consensus rating and higher possible upside, analysts clearly believe Edap Tms is more favorable than Paradigm Medical Industries.

Earnings & Valuation

This table compares Paradigm Medical Industries and Edap Tms”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paradigm Medical Industries	N/A	N/A	N/A	N/A	N/A
Edap Tms	$69.18 million	2.30	-$20.58 million	($0.57)	-7.46

Paradigm Medical Industries has higher earnings, but lower revenue than Edap Tms.

Summary

Edap Tms beats Paradigm Medical Industries on 5 of the 9 factors compared between the two stocks.

About Paradigm Medical Industries

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.